NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.91 -0.45 (-0.54%) GOLD FUTURES
2,332.20 -9.90 (-0.42%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,351.42 -1,887.98 (-3.55%)
STAAR Surgical Company (STAA)
After hours:
- Zacks
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Investor's Business Daily
Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive?
Staar Surgical preannounced strong first-quarter sales on Thursday, helping Staar stock retake its 200-day line and hit a seven-month high.
- Benzinga
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
Thursday, STAAR Surgical Company (NASDAQ:STAA) reported preliminary net sales for the first quarter of 2024 of more than $77 million versus the consensus of $72.13 million, with U.S. ICL sales expected to be $5 million for the quarter. This represents the company’s highest quarterly ICL sales in the U.S. since the company obtained U.S. FDA approval for the EVO ICL in March 2022. “STAAR is off to a solid start in 2024 as illustrated by our preliminary first quarter results, including a record qua
